Clinical Trial Update: Escitalopram (Lexapro) for Depression MS or ALS [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating escitalopram for depression in patients with multiple sclerosis or ALS has completed with results posted in 2011.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Amyotrophic Lateral Sclerosis
• Major Depression
• Multiple Sclerosis

Drugs mentioned

• Lexapro (escitalopram)

Snippet

Sponsor: University of South Carolina | Conditions: Major Depression, Multiple Sclerosis | Phase 3 | Status: COMPLETED | Results posted: 2011-09-07